Xenon Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 49.66 M54.38 M61.65 M64.23 M71.75 M81.48 M 279.12 M Cash from investing activities 498 K98.5 M34.51 M82.26 M38.53 M62.7 M 218 M Cash from financing activities —12.13 M1.15 M65 K2.36 M113.54 M 117.11 M Free cash flow 49.08 M53.6 M61.61 M64.08 M71.47 M81.16 M 278.32 M

News

Alibaba Earnings, Jobs Data

Xenon Pharmaceuticals hissesi 46,68 dolarla zirve yaptı

Xenon Pharmaceuticals stock hits 52-week high at $46.68

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Xenon earnings loom as investors brace for Phase 3 catalyst

Wolfe Research, Xenon Pharmaceuticals hissesine alım tavsiyesi verdi

Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

Stifel, XEN1101’in potansiyeli nedeniyle Xenon Pharmaceuticals hedef fiyatını 66 dolara yükseltti

Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential

Biohaven stock rating upgraded by RBC Capital on promising CNS data

Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:XENE) 2026-01-12